Cytomegalovirus
Studies from University of California Provide New Data on Cytomegalovirus
Published in Vaccine Weekly, October 19th, 2011
2011 OCT 19 -- New research, "Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection," is the subject of a report. According to the authors of recent research from San Francisco, California, "Human cytomegalovirus (HCMV) is the major viral cause of birth defects worldwide. Affected infants can have temporary symptoms that resolve soon after birth, such as growth restriction, and permanent disabilities, including neurological impairment."
"Passive immunization of pregnant women with primary HCMV infection is a promising treatment to prevent congenital...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2011-10-19)
More Articles from Vaccine Weekly
- Nurse Practitioners
Studies in the Area of Nurse Practitioners Reported from A. Adorador and Co-Researchers - Cytokines
CEL-SCI Corporation to Raise $4 Million in Registered Direct Offering - Vaccines
CoMeD Challenges U.S. Government on Mercury in Vaccines - Leptospirosis
Data from International Medical University Provide New Insights into Leptospirosis - Vaccines
Data from POSTECH Advance Knowledge in Vaccines - Hepatitis A virus
Data on Hepatitis A virus Reported by Researchers at Kyung Hee University - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
